Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
D. G. Couch, Chris Tasker, Elena Theophilidou, et al.
Clinical Science (2017) Vol. 131, Iss. 21, pp. 2611-2626
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders
Marija Branković, Tijana Gmizić, Marija Dukić, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 600-600
Open Access | Times Cited: 5
Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion
Tanya J. Little, Nada Cvijanovic, Nicholas V. DiPatrizio, et al.
AJP Endocrinology and Metabolism (2018) Vol. 315, Iss. 4, pp. E489-E495
Open Access | Times Cited: 40
Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects
Ester Pagano, Tommaso Venneri, Giuseppe Lucariello, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1923-1923
Open Access | Times Cited: 32
Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing
A.C.B. van Orten-Luiten, Nicole M. de Roos, Soumia Majait, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 4, pp. 436-444
Open Access | Times Cited: 28
The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
Jinpeng Li, Ricardo Carvajal, Leon H. Bruner, et al.
Food and Chemical Toxicology (2021) Vol. 157, pp. 112600-112600
Open Access | Times Cited: 27
Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways
Lin Li, Yaowei Xuan, Biao Zhu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 20
Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Chaobiao Yan, Li Yu, Hanqing Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188905-188905
Closed Access | Times Cited: 12
Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals
Yang Yang, Gang Xiao, Pi Cheng, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6811-6811
Open Access | Times Cited: 11
Utilization of Cannabidiol in Post-Organ-Transplant Care
Sachiko Koyama, Jumar Etkins, Jin-Sun Jun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 699-699
Open Access
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Dinesh Thapa, Anshu Ghimire, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 478-478
Open Access
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα
Mustafa Karwad, D. G. Couch, Karen L. Wright, et al.
Biochemical Pharmacology (2019) Vol. 168, pp. 465-472
Open Access | Times Cited: 31
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Gioacchino Calapai, Carmen Mannucci, İoanna Chinou, et al.
Evidence-based Complementary and Alternative Medicine (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 31
Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract
Agnese Stanzani, Giorgia Galiazzo, Fiorella Giancola, et al.
Histochemistry and Cell Biology (2020) Vol. 153, Iss. 5, pp. 339-356
Closed Access | Times Cited: 31
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Emilia Carbone, Antonia Manduca, Claudia Cacchione, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 121, pp. 128-143
Closed Access | Times Cited: 29
Cannabidiol nanoemulsion for eye treatment – Anti-inflammatory, wound healing activity and its bioavailability using in vitro human corneal substitute
V.N. Tran, Ondřej Strnad, Jáchym Šuman, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123202-123202
Open Access | Times Cited: 10
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
Antonelly Cassio Alves de Carvalho, Gabriela Achete de Souza, Sâmylla Vaz de Marqui, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2940-2940
Open Access | Times Cited: 27
Cannabis and the Gastrointestinal Tract
Lawrence Cohen, Manuela G. Neuman
Journal of Pharmacy & Pharmaceutical Sciences (2020) Vol. 23, pp. 301-313
Open Access | Times Cited: 21
Effect of the dietary supplement PERMEAPROTECT+ TOLERANCE© on gut permeability in a human co-culture epithelial and immune cells model
Anne Abot, Nicolas Pomié, Gwendoline Astre, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28320-e28320
Open Access | Times Cited: 2
The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut
Kevin Brown, Kyle Funk, Alexa Figueroa Barrientos, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1618-1618
Open Access | Times Cited: 2
The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study
Loredana Raciti, Rosaria De Luca, Gianfranco Raciti, et al.
Medical Sciences (2022) Vol. 10, Iss. 3, pp. 37-37
Open Access | Times Cited: 11
Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds
Anna Rybarczyk, Aleksandra Majchrzak‐Celińska, Violetta Krajka‐Kuźniak
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2052-2052
Open Access | Times Cited: 6
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
Christopher N. Andrews, Shane Devlin, Bernard Le Foll, et al.
Journal of the Canadian Association of Gastroenterology (2018) Vol. 2, Iss. 1, pp. 37-43
Open Access | Times Cited: 19
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review
Mellar P. Davis, Bertrand Behm, Zankhana Mehta, et al.
American Journal of Hospice and Palliative Medicine® (2019) Vol. 36, Iss. 12, pp. 1134-1154
Closed Access | Times Cited: 18
Phytotherapics in COVID19: Why palmitoylethanolamide?
Marcella Pesce, Luisa Seguella, Sara Cassarano, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 5, pp. 2514-2522
Open Access | Times Cited: 16

Scroll to top